Cargando…
Clinical potential of the Hippo-YAP pathway in bladder cancer
Bladder cancer (BC) is one of the world’s most frequent cancers. Surgery coupled with adjuvant platinum-based chemotherapy is the current standard of therapy for BC. However, a high proportion of patients progressed to chemotherapy-resistant or even neoplasm recurrence. Hence, identifying novel trea...
Autores principales: | Cheng, Xin, Lou, Kecheng, Ding, Liang, Zou, Xiaofeng, Huang, Ruohui, Xu, Gang, Zou, Junrong, Zhang, Guoxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336529/ https://www.ncbi.nlm.nih.gov/pubmed/35912245 http://dx.doi.org/10.3389/fonc.2022.925278 |
Ejemplares similares
-
Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer
por: Lou, Kecheng, et al.
Publicado: (2022) -
The Potential Role of Exosomal Proteins in Prostate Cancer
por: Feng, Shangzhi, et al.
Publicado: (2022) -
Obesity-Related Cross-Talk between Prostate Cancer and Peripheral Fat: Potential Role of Exosomes
por: Feng, Shangzhi, et al.
Publicado: (2022) -
Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023) -
Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway
por: Cai, Yuanxia, et al.
Publicado: (2020)